Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2026-02-11 @ 8:01 PM
Study NCT ID:
NCT05811793
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-04-13
First Post:
2023-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
Sponsor:
Second Affiliated Hospital of Nanchang University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Glioblastoma | View |
Keywords: